The Mor institute network recently announced an expansion of its diagnostic services and the launch of a new and advanced service for examining the small intestine using an endoscopic capsule - a non-invasive, innovative test that provides comprehensive and highly accurate diagnostic imaging. The test is based on advanced PillCam technology, which integrates artificial intelligence capabilities and enables high-quality scanning of the small intestine - an area that is difficult to reach using conventional endoscopic methods.
Who is the test intended for?
The test is intended for patients in the following situations:
Investigation of unexplained gastrointestinal bleeding after endoscopic examinations
Suspected inflammatory bowel disease, including Crohn’s disease
Monitoring of patients with known Crohn’s disease
The examination process:
The examination begins with a medical intake session that includes a comprehensive interview and detailed explanation. The patient then swallows a small capsule equipped with a camera and is connected to a dedicated receiver via a belt. The capsule transmits images throughout the digestive tract without requiring an invasive procedure. The receiver is removed after approximately 12–14 hours, and the data is then interpreted by a senior gastroenterologist. The results are uploaded to the Mor system and sent to the referring physician.
After the request for the test is submitted, a senior Mor physician reviews the patient’s medical suitability. Once the test is approved, an appointment is scheduled and a detailed preparation instructions are sent. In some cases, a preliminary capsule test may be required.
A benefit for patients and physicians
At Mor, it is noted that the new service is expected to significantly improve the quality and availability of diagnostics, and enable physicians to obtain a broader and more accurate clinical picture - supporting optimal treatment decisions for patients. Dr. Nicky Liebermann, Medical Director of Mor Institute, said: “We are pleased to make this advanced test accessible at Mor branches throughout the country with high availability and quality. The test is intended to assist in diagnosing processes in the small intestine, which are usually not accessible through other convenient imaging methods, and of course in monitoring inflammatory bowel diseases for detection and therapeutic decision-making.”